Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,219,376
+$2,832,822 QoQ
Shares Held
83,035
+13.1% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $1,467,551,041 across 98 Biotechnology names. RYTM ranks #27 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
559,445 | $277,893,114 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
421,976 | $263,118,914 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,844,692 | $200,977,489 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
248,355 | $78,502,531 | |
| 5 | CAI |
Caris Life Sciences, Inc.
|
3,590,963 | $63,990,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
633,533 | $50,232,830 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
552,158 | $41,124,727 | |
| 8 | INSM |
INSMED Inc
|
378,816 | $40,389,361 |
All Filings in RYTM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,219,376 | 83,035 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,386,554 | 73,434 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,875,146 | 73,572 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,595,965 | 85,117 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,443,123 | 86,139 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $3,598,728 | 67,939 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||